High-Dose Intra-Dermal Hepatitis B Vaccine in a Liver Transplant Patient Who Failed Prior Intramuscular Vaccination: A Brief Case Report
- 1 Division of Gastroenterology and Hepatology, Saint Francis Medical Center, Peoria, USA
- 2 Divison of Digestive Diseases, Rush University Medical Center, Chicago, USA
- 3 Divison of Digestive Diseases, Rush University Medical Center, Chicago, USA
- 4 University of California, Davis, USA
- 5 Divison of Digestive Diseases, Rush University Medical Center, Chicago, USA
Abstract
Hepatitis B virus (HBV) chronic infection represents a significant cause of morbidity and mortality worldwide. While traditional intramuscular (IM) HBV vaccination is an excellent method for robust and sustained seroconversion in healthy individuals, its efficacy in chronic liver disease is sub-optimal and scant data exists in the post-liver transplant state. Importantly, HBV complications are even more severe in these same immunocompromised populations. In tra-dermal (ID) vaccination has shown initial promise as a successful alternative to achieving HBV seroconversion in patients refractory to standard vaccination protocols. Herein is a case report of a 61 year-old female who underwent liver transplantation for chronic HBV infection and achieved HBsAg seroconversion with a robust HSsAb titer with ID vaccination after having failed both standard and double dose IM vaccination.
- C. W. Shepard, E. P. Simard, L. Finelli, A. E. Fiore and B. P. Bell, “Hepatitis B Virus Infection: Epidemiology and Vaccination,” Epidemiologic Reviews, Vol. 28, No. 1, 2006, pp. 112-125. doi:10.1093/epirev/mxj009
- A. R. Zanetti, P. Van Damme and D. S. Vaccine, “The Global Impact of Vaccination against Hepatitis B: A Historical Overview,” Vaccine, Vol. 26, No. 49, 2008, pp. 6266-6273. doi:10.1016/j.vaccine.2008.09.056
- N. A. Terrault and T. L. Wright, “Hepatitis B Virus Infection and Liver Transplantation,” Gut, Vol. 40, No. 5, 1997, pp. 568-571.
- J. P. Lerut, M. Donataccio, O. Ciccarelli, et al., “Liver Transplantation and HBsAg-Positive Postnecrotic Cirrhosis: Adequate Immunoprophylaxis and Delta Virus Co-Infection as the Significant Determinants of Long-Term Prognosis,” Journal of Hepatology, Vol. 30, No. 4, 1999, pp. 706-714. doi:10.1016/S0168-8278(99)80203-7
- M. Wiedmann, U. G. Liebert, U. Oesen, H. Porst, M. Wiese, S. Schroeder, U. Halm, J. Mossner and F. Berr, “Decreased Immunogenicity of Recombinant Hepatitis B Vaccine in Chronic Hepatitis C. Hepatology,” Vol. 31, No. 1, 2000, pp. 230-234. doi:10.1002/hep.510310134
- U. Bienzle, M. Günther, R. Neuhaus, P. Vandepapeliere, J. Vollmar, A. Lun and P. Neuhaus, “Immunization with an Adjuvant Hepatitis B Vaccine after Liver Transplantation for Hepatitis B-Related Disease,” Hepatology, Vol. 38, No. 4, 2003, pp. 811-819.
- M. Arslan, R. H. Wiesner, C. Sievers, K. Egan, N. N. Zein, “Double-Dose Accelerated Hepatitis B Vaccine in Patients with End-Stage Liver Disease,” Liver Transplantation, Vol. 7, No. 4, 2001, pp. 314-320. doi:10.1053/jlts.2001.23069
- C. M. Lo, C. L. Liu, S. C. Chan, G. K. Lau and S. T. Fan, “Failure of Hepatitis B Vaccination in Patients Receiving Lamivudine Prophylaxis after Liver Transplantation for Chronic Hepatitis B,” Journal of Hepatology, Vol. 43, No. 2, 2005, pp. 283-287. doi:10.1016/j.jhep.2005.03.013
- F. Fabrizi, V. Dixit, P. Messa and P. Martin, “Intradermal vs Intramuscular Vaccine against Hepatitis B Infection in Dialysis Patients: A Meta-Analysis of Randomized Trials,” Journal of Viral Hepatitis, Vol. 18, No. 10, 2010, pp. 730-737.
- A. Aziz, S. Aziz, D. S. Li, L. Murphy, N. Leone, M. Kennedy, S. Dhillon and D. H. Van Thiel, “Efficacy of Repeated High-Dose Hepatitis B Vaccine (80 μg) in Patients with Chronic Liver Disease,” Journal of Viral Hepatitis, Vol. 13, No. 4, 2006, pp. 217-221. doi:10.1111/j.1365-2893.2005.00674.x